Cryopreserved apoptotic mesenchymal stromal cells retain functional efficacy in suppressing an allergic inflammation in a murine model.

Autor: Amison RT; Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Cheung TS; School of Cancer and Pharmacological Sciences King's College London, London, United Kingdom., Giacomini C; School of Cancer and Pharmacological Sciences King's College London, London, United Kingdom.; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom., Riffo-Vasquez Y; Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Galleu A; School of Cancer and Pharmacological Sciences King's College London, London, United Kingdom., Savoldelli R; BioPharmaceuticals R&D Cell therapy, AstraZeneca, Cambridge, United Kingdom., Hicks R; BioPharmaceuticals R&D Cell therapy, AstraZeneca, Cambridge, United Kingdom., Kozlowska A; BioPharmaceuticals R&D Cell therapy, AstraZeneca, Cambridge, United Kingdom., Dazzi F; School of Cancer and Pharmacological Sciences King's College London, London, United Kingdom.; School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom.; BioPharmaceuticals R&D Cell therapy, AstraZeneca, Cambridge, United Kingdom.

Publikováno v: Stem cells translational medicine [Stem Cells Transl Med] 2024 Oct 10; Vol. 13 (10), pp. 979-984.

In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery

Autor: Woods, A., Patel, A., Spina, D., Riffo-Vasquez, Y., Babin-Morgan, A., de Rosales, R.T.M., Sunassee, K., Clark, S., Collins, H., Bruce, K., Dailey, L.A., Forbes, B.

Publikováno v: In Journal of Controlled Release 28 July 2015 210:1-9

Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1.

Autor: Riffo-Vasquez Y; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., Kanabar V; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., Keir SD; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., E-Lacerda RR; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., Man F; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., Jackson DJ; Asthma Care Guy's & St Thomas' NHS Trust, London, UK.; Faculty of Life Sciences and Medicine, MRC & Asthma UK Centre, Guy's Hospital, King's College London, London, UK., Corrigall V; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK., Coates ARM; Medical Microbiology, Institute of Infection and Immunity, St George's, University of London, London, UK., Page CP; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Sciences, King's College London, London, UK.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2020 Apr; Vol. 50 (4), pp. 508-519. Date of Electronic Publication: 2020 Jan 15.

Sex differences in the influence of obesity on a murine model of allergic lung inflammation.

Autor: E-Lacerda RR; Sackler Institute of Pulmonary Pharmacology, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Departamento de Farmacologia, Universidade Estadual de Campinas, Campinas, Brazil., Anhê GF; Departamento de Farmacologia, Universidade Estadual de Campinas, Campinas, Brazil., Page CP; Sackler Institute of Pulmonary Pharmacology, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Riffo-Vasquez Y; Sackler Institute of Pulmonary Pharmacology, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2020 Feb; Vol. 50 (2), pp. 256-266. Date of Electronic Publication: 2019 Dec 06.

A peptide derived from chaperonin 60.1, IRL201104, inhibits LPS-induced acute lung inflammation.

Autor: Man F; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Nadkarni S; William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom., Kanabar V; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., E-Lacerda RR; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Gomes Ferreira S; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Federici Canova D; William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom., Perretti M; William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom., Page CP; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Riffo-Vasquez Y; Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, London, United Kingdom.

Publikováno v: American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2021 Nov 01; Vol. 321 (5), pp. L803-L813. Date of Electronic Publication: 2021 Aug 25.